Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

The Sanming Model: The Path for China's Healthcare Reform?

publication date: Apr 18, 2017
The future for China healthcare may have been discovered in Sanming, a smaller city located in Fujian Province on China's southeast coast. In 2011, the metropolitan area, whose healthcare system suffered from much the same difficulties as other China cities, was also facing a specific problem: one of its insurance funds was running a large deficit. Instead of addressing that issue as a standalone difficulty, Sanming decided it would attempt a comprehensive reform. It would consider matters such as drug pricing, unequal coverage of individual insurance plans, hospital revenue structure and salaries for health workers. It found that these seemingly separate, fairly difficult problems were in fact interrelated. By aiming for a comprehensive solution, it moved towards a healthcare delivery system that solved its immediate problem and some long-term structural difficulties. It seems to work better for everyone. More details....

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital